COVID-19 Vaccination Super Loads Body with Excessive Spike Protein

Injecting mRNA after SARS-CoV-2 Infection Builds a Bigger Enemy Within Us

By Peter A. McCullough, MD, MPH

Measurement of antibodies to the SARS-CoV-2 Spike protein is routine community standard of care in the assessment of long-COVID and vaccine injury syndromes. I have noticed that the most ill patients are those who had COVID-19 early and then took one or more ill-advised COVID-19 vaccines. Recall the US FDA did not allow Pfizer or Moderna to vaccinate COVID-19 recovered patients in the registration clinical trials because they had great expected harm and no opportunity for clinical benefit. Later, three studies demonstrated that indeed vaccination after infection was a bad idea with much greater risks of serious adverse events than SARS-CoV-2 naive patients.

Kayukawa S, Nanya K, Morita M, Ina K, Ota Y, Hasegawa S. Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2. Microbiol Spectr. 2021 Dec 22;9(3):e0103621. doi: 10.1128/Spectrum.01036-21. Epub 2021 Nov 10. PMID: 34756062; PMCID: PMC8579918.

Kayukawa et al demonstrated the expected finding. Antibodies go up with infection but because this is a natural process where the body fights SARS-CoV-2 on mucosal surfaces, the serological rise is low. However, vaccination after infection gives a huge rise in anti-spike antibodies implying the body is super-loaded with Spike. I wonder if anyone knew we would be seeing evidence of persistent Spike three years after the primary series.